Lataa...
The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75
Lens-epithelium-derived growth-factor (LEDGF/p75)-binding site on HIV-1 integrase (IN), is an attractive target for antiviral chemotherapy. Small-molecule compounds binding to this site are referred as LEDGF-IN inhibitors (LEDGINs). In this study, compound libraries were screened to identify new inh...
Tallennettuna:
| Julkaisussa: | J Enzyme Inhib Med Chem |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170385/ https://ncbi.nlm.nih.gov/pubmed/32228103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2020.1743282 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|